Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Radiofrequency (RF) Ablation Prospective Outcomes Study

NCT: NCT04673032 · COMPLETED

NCT IDNCT04673032
StatusCOMPLETED
Start Date2020-12-22
Completion2025-02-07

Brief Summary

The objective of this study is to compile real-world outcomes of Boston Scientific commercially approved radiofrequency (RF) ablation systems in the treatment of patients diagnosed with pain

Frequently Asked Questions

What is Radiofrequency (RF) Ablation Prospective Outcomes Study?

Radiofrequency (RF) Ablation Prospective Outcomes Study is a clinical trial registered under NCT04673032. Current status: COMPLETED.

What is the status of NCT04673032?

The current status of NCT04673032 (Radiofrequency (RF) Ablation Prospective Outcomes Study) is: COMPLETED.

When did Radiofrequency (RF) Ablation Prospective Outcomes Study start?

Radiofrequency (RF) Ablation Prospective Outcomes Study started on 2020-12-22.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.